Toggle Main Menu Toggle Search

Open Access padlockePrints

100x longevity improvement of optoelectronic implants through balancing integral electric fields

Lookup NU author(s): Dr Reza Ramezani, Peimin Yuan, Dimitrios Firfilionis, Professor Patrick DegenaarORCiD

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

Photonics and Optoelectronics are becoming increasingly important for use in implantable devices. In animal trials, although not desirable, failure can lead to the direct replacement of either the component or the test subject. In human implementations, however, the longevity of implantable devices typically needs to exceed 5 years and, in some cases, decades. Traditional hermetic metal packages, per definition, are impervious to water vapour. However, such packaging is unsuitable for structures which are millimetre sized or less. Brain probes encompassing optical micro-emitters must, therefore, use protective passivation/encapsulation layers such as silicon oxynitrides/silicone. However, such protection is prone to electrolytic failure driven by the LED-driving voltages. In this paper, we describe an electrical driving methodology which can improve device lifetime of encapsulated devices by balancing time-averaged electric fields to zero. We have tested the method on commercial optrodes to demonstrate platform independence. We show that, with this method, the time to failure can be increased by over two orders of magnitude.


Publication metadata

Author(s): Ramezani R, Soltan A, Yuan P, Firfilionis D, Donaldson N, Degenaar P

Publication type: Article

Publication status: Published

Journal: IEEE Transactions on Biomedical Engineering

Year: 2025

Pages: epub ahead of print

Online publication date: 03/11/2025

Acceptance date: 30/10/2025

Date deposited: 11/11/2025

ISSN (print): 0018-9294

ISSN (electronic): 1558-2531

Publisher: IEEE

URL: https://doi.org/10.1109/TBME.2025.3628446

DOI: 10.1109/TBME.2025.3628446

ePrints DOI: 10.57711/ztzr-kr71

PubMed id: 41182931


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
102037/Z/13/ZWellcome Trust
EPSRC NS/A000026/1

Share